Indepth intake assessment and medical history review
We will talk about personal and family history, what you've tried, what works and what doesn't, and your personal goals (the "why" behind your weight loss).
← Home
Metabolic Reset and Weight Loss Program
Medical weight-loss care that looks at the bigger picture.
Why Choose this Program?
I guide a metabolic reset and weight loss journey for adult women who have hormone-related weight issues (thyroid disease, PCOS, perimenopause, and menopause), feel tired all the time, and cannot seem to lose weight despite diet, exercise, and weight loss medications (yes, including GLP-1 medications). I understand the bigger picture in weight loss - you deserve better than medication and list of dos and don'ts.
Customized GLP-1 plan
Personalized dosing adjustments.
Sleep apnea testing*
Sleep apnea is detrimental to weight loss, because it disrupts hormones, slows metabolism, and causes fatigue that prevents you from increasing physical activity. Sleep apnea is also associated with high blood pressure, heart attacks, strokes, diabetes, and death.
Cortisol testing**
If you do not achieve at least 5% weight loss within the first 3 months of treatment, there could be an underlying medical issue preventing weight loss. The same concept applies when the medication stops working despite increase in dose and continued lifestyle changes. Oftentimes cortisol "the stress hormone" is to blame.
Labs initially, then every 3 months
Included in the program. Monitoring your blood work is another way to measure non-scale victories.
Video visit scheduled with me once a month
Monthly care and review.
Monthly check-in form review
We will discuss your questions/concerns and celebrate your scale and non-scale victories.
Unlimited secure messaging
Need me in-between appointments? I will respond to your message within 24 hours on business days.
*Scheduled and completed during the first month of the program. **Included in 4th month of the program.
What You Will Achieve
Metabolic reset and healthy, monitored weight loss. Most patients lose more than 5% of their body weight by the end of the first 3 months on GLP-1 medication. For those who CANNOT lose at least 5% of their body weight within the first 3 months, there is usually an underlying medical condition preventing weight loss. If this is you, then you are not alone. I will help you find the reason and point you in the direction of a resolution.
What's Included
- Intake assessment and medical history review
- 40-minute initial video consult
- 20-minute video follow up once a month, starting with month 2
- Customized GLP-1 plan
- Monthly compound medication shipped to your door
- Monthly check-in form review (discussed on your monthly visit)
- Personalized dosing adjustments
- Unlimited secure messaging
- Labs (CBC, CMP, A1C, TSH, LIPID PANEL) once every 3 months
- Cortisol testing (one time), on month 4
- Sleep apnea testing (one time in the first month) through a home sleep test
What the program costs
Pricing is published openly so you can decide before you commit. The initial weight loss visit is $50 and is separate from the program.
| Program | Price | Savings |
|---|---|---|
| Month to month | $599 / month | — |
| Silver, 3 months | $1,500 | save $297 |
| Gold, 6 months | $3,000 | save $594 |
| Platinum, 12 months | $6,000 | save $1,188 |
Included in the program price: your monthly video visit, compounded medication shipped to you, labs every three months, sleep apnea testing in the first month, one-time cortisol testing, dose adjustments and unlimited secure messaging.
Not included: the $50 initial weight loss visit, any office visits outside the program, imaging, and services from outside providers.
Prices valid through the end of 2026. The clinic is cash-pay while insurance credentialing is in progress.
Who this program is for — and who it is not for
This program is designed for adult women with hormone-related weight concerns: thyroid disease, PCOS, perimenopause and menopause, particularly when diet, exercise and previous weight loss medication have not worked.
Whether you are a candidate is decided at your evaluation, not on a website. GLP-1 medication is not appropriate for everyone. It should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and it is not used in pregnancy or while trying to become pregnant. A history of pancreatitis, gallbladder disease, severe gastrointestinal disease, certain eating disorders, or specific diabetes medications all change the picture. That is what the history, exam and labs are for.
What your evaluation covers
An in-office visit and urine drug screen are required before medication in this program is prescribed. Labs include CBC, CMP, A1C, TSH and a lipid panel, repeated every three months. Sleep apnea testing happens in the first month through a home sleep test, and one-time cortisol testing in month four. Testing is selected according to your history, symptoms and examination; no test is guaranteed to identify a cause of limited weight loss.
About the medication
When medication is appropriate, FDA-approved options are discussed first. A compounded medication may be considered only when it is lawful, clinically appropriate for you, and prescribed to meet a documented patient-specific need.
Compounded GLP-1 products are custom-compounded, vary from pharmacy to pharmacy, have not been evaluated or approved by the FDA for safety, efficacy or quality, and require a valid prescription from a licensed healthcare provider after an individual medical evaluation. They are not generic versions of brand-name medications such as Ozempic, Wegovy, Mounjaro or Zepbound. Enrolling in a program does not guarantee that any medication will be prescribed, compounded, available or appropriate for you.
Risks and side effects
Common adverse effects include nausea, vomiting, diarrhea, constipation and abdominal symptoms. Their severity and duration vary — contact the clinic for persistent or severe symptoms. More serious risks reported with these medications include pancreatitis, gallbladder disease, kidney injury from dehydration, and low blood sugar when combined with certain diabetes medications.
FDA-approved semaglutide and tirzepatide products carry boxed warnings concerning thyroid C-cell tumors observed in rodents; it is not known whether they cause these tumors in humans. The exact warnings depend on the product prescribed.
This is not a complete list. Your own history determines which risks matter for you, and that conversation happens at your visit.
What happens if progress is slower than expected
Weight-loss results vary and no specific amount or timeline can be guaranteed. If progress is less than expected, Carolyn will reassess treatment response, adherence, side effects, dosing, lifestyle factors and other medications, and whether your symptoms or examination support evaluation for another condition.
This page is general health education, not individual medical advice, and it does not create a patient-provider relationship. Risk information below is adapted from current FDA prescribing information for the FDA-approved semaglutide and tirzepatide products; compounded preparations do not have FDA-approved labeling and may differ. Ask Carolyn and the dispensing pharmacy about the exact product proposed for you.
More answers on the FAQ page.
Ready to discuss medical weight loss?
Call to schedule an individual medical evaluation.